Randall Kaye, CMO at Longboard Pharmaceuticals, Inc. (LBPH), sold 33,334 shares at $59.04 ($2.0M) on 2024-10-15, disclosed to the SEC on 2024-10-16.
Scheduled sale ($2.0M) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.04 | 16,667 | $984K | 50.0% |
| 2 | $59.04 | 16,667 | $984K | 50.0% |
| Total | $59.04 avg | 33,334 | $2.0M | 100% |
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |
| AVNR | SELL | 2011-09-13 | $275K | — | Filing → |